Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Welte

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The Journal of General Virology|May 1, 2009
Virulence variation among isolates of western equine encephalitis virus in an outbred mouse modelChristopher H Logue, Christopher F Bosio, Thomas Welte, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2003
STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunityThomas Welte, Samuel S M Zhang, Tian Wang, et al.
Cancer Research|December 9, 2024
Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell TumorsThomas Welte, Veena K Vuttaradhi, Eleonora Y Khlebus, et al.
Gynecologic Oncology|August 31, 2025
Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor modelsAllison L Brodsky, Thomas Welte, Veena K Vuttaradhi, et al.
Cancer Cell|January 21, 2015
The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cellsHai Wang, Cuijuan Yu, Xia Gao, et al.
Molecular Cancer Research : MCR|April 17, 2023
Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell TumorsEleonora Khlebus, Veena K Vuttaradhi, Thomas Welte, et al.
Nature|April 4, 2017
Mutual regulation of tumour vessel normalization and immunostimulatory reprogrammingLin Tian, Amit Goldstein, Hai Wang, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized levelMukulika Bose, Cole Ruoff, Shafqat Ehsan, et al.
Nature Communications|April 10, 2023
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patientLena Jaki, Sebastian Weigang, Lisa Kern, et al.
Nature Cell Biology|June 29, 2016
Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiationThomas Welte, Ik Sun Kim, Lin Tian, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The Journal of General Virology|May 1, 2009
Virulence variation among isolates of western equine encephalitis virus in an outbred mouse modelChristopher H Logue, Christopher F Bosio, Thomas Welte, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2003
STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunityThomas Welte, Samuel S M Zhang, Tian Wang, et al.
Cancer Research|December 9, 2024
Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell TumorsThomas Welte, Veena K Vuttaradhi, Eleonora Y Khlebus, et al.
Gynecologic Oncology|August 31, 2025
Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor modelsAllison L Brodsky, Thomas Welte, Veena K Vuttaradhi, et al.
Cancer Cell|January 21, 2015
The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cellsHai Wang, Cuijuan Yu, Xia Gao, et al.
Molecular Cancer Research : MCR|April 17, 2023
Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell TumorsEleonora Khlebus, Veena K Vuttaradhi, Thomas Welte, et al.
Nature|April 4, 2017
Mutual regulation of tumour vessel normalization and immunostimulatory reprogrammingLin Tian, Amit Goldstein, Hai Wang, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized levelMukulika Bose, Cole Ruoff, Shafqat Ehsan, et al.
Nature Communications|April 10, 2023
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patientLena Jaki, Sebastian Weigang, Lisa Kern, et al.
Nature Cell Biology|June 29, 2016
Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiationThomas Welte, Ik Sun Kim, Lin Tian, et al.
Pageof 8